These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23961831)

  • 21. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
    Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
    Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired drug absorption due to high stomach pH: a review of strategies for mitigation of such effect to enable pharmaceutical product development.
    Mitra A; Kesisoglou F
    Mol Pharm; 2013 Nov; 10(11):3970-9. PubMed ID: 23844623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
    Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
    Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
    Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys.
    Christopher LJ; Cui D; Li W; Barros A; Arora VK; Zhang H; Wang L; Zhang D; Manning JA; He K; Fletcher AM; Ogan M; Lago M; Bonacorsi SJ; Humphreys WG; Iyer RA
    Drug Metab Dispos; 2008 Jul; 36(7):1341-56. PubMed ID: 18420785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
    Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
    Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
    Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
    J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
    Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
    Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat.
    Froment DH; Buddington B; Miller NL; Alfrey AC
    J Lab Clin Med; 1989 Sep; 114(3):237-42. PubMed ID: 2769017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using pH Gradient Dissolution with In-Situ Flux Measurement to Evaluate Bioavailability and DDI for Formulated Poorly Soluble Drug Products.
    Li J; Tsinman K; Tsinman O; Wigman L
    AAPS PharmSciTech; 2018 Oct; 19(7):2898-2907. PubMed ID: 30209787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion.
    Park YJ; Lee HK; Im YB; Lee W; Han HK
    Arch Pharm Res; 2010 Aug; 33(8):1235-40. PubMed ID: 20803127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of in Silico Tools in Clinical Practice using Ketoconazole as a Model Drug.
    Silva DA; Duque MD; Davies NM; Löbenberg R; Ferraz HG
    J Pharm Pharm Sci; 2018; 21(1s):242s-253s. PubMed ID: 30348250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
    Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
    Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
    Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Piperazine Dithioctate on the Oral Pharmacokinetics of Glimepiride in Rats.
    Kim EY; Yu K; Choi K; Yu HE; Oh SJ; Lee K
    Biol Pharm Bull; 2015; 38(8):1161-8. PubMed ID: 26235578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of central and peripheral administration of pancreatic polypeptide on gastric mucosa growth.
    Dembiński A; Warzecha Z; Ceranowicz P; Pawlik M; Dembiński M; Kabat K; Konturek SJ; Kownacki P; Hładki W; Pawlik WW
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):223-37. PubMed ID: 15082880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay of dissolution, solubility, and nonsink permeation determines the oral absorption of the Hedgehog pathway inhibitor GDC-0449 in dogs: an investigation using preclinical studies and physiologically based pharmacokinetic modeling.
    Wong H; Theil FP; Cui Y; Marsters JC; Khojasteh SC; Vernillet L; La H; Song X; Wang H; Morinello EJ; Deng Y; Hop CE
    Drug Metab Dispos; 2010 Jul; 38(7):1029-38. PubMed ID: 20406853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats.
    Vuppugalla R; Zhang Y; Chang S; Rodrigues AD; Marathe PH
    Xenobiotica; 2012 Nov; 42(11):1058-68. PubMed ID: 22574883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.